Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04730349
Title A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer (PIVOT IO 020)
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb


acute lymphoblastic leukemia

non-Hodgkin lymphoma

Advanced Solid Tumor

central nervous system cancer


Nivolumab + NKTR-214

Age Groups: adult | child
Covered Countries USA | ITA | FRA | ESP | DEU

No variant requirements are available.